Handle With Care: Gilead Sciences, Inc. (NASDAQ: GILD)
Capital Research & Management Co recently announced the acquisition of new stake in Gilead Sciences, Inc. (NASDAQ:GILD). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 81.72 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 6.56% valued currently at $6.26 billion. In […]
Gilead Sciences, Inc. (GILD) Volatility Spurs A Quest For Clarity
Capital Research & Management Co recently announced the acquisition of new stake in Gilead Sciences, Inc. (NASDAQ:GILD). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 81.72 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 6.56% valued currently at $6.42 billion. In […]
Gilead Sciences, Inc. (NASDAQ: GILD) – Suitable For Long Term Buy?
With over 7.5 million Gilead Sciences, Inc. (GILD) shares trading Monday and a closing price of $78.34 on the day, the dollar volume was approximately $587.66 million. The shares have shown a positive half year performance of 0.80% and its price on 12/04/23 gained nearly 0.89%. Currently, there are 1.25B common shares owned by the […]
Handle With Care: Gilead Sciences, Inc. (NASDAQ: GILD)
Capital Research & Management Co recently announced the acquisition of new stake in Gilead Sciences, Inc. (NASDAQ:GILD). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 81.72 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 6.56% valued currently at $6.42 billion. In […]
Now Is A Suitable Moment For A Long-Term Purchase Of Gilead Sciences, Inc. (NASDAQ: GILD)
Capital Research & Management Co recently announced the acquisition of new stake in Gilead Sciences, Inc. (NASDAQ:GILD). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 81.72 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 6.56% valued currently at $6.42 billion. In […]
